May 4, 2022

Dr. Kevin Kalinsky discusses updates from the TAILORx breast cancer trial

April 29, 2022

Interview with Dr. Robert Ferris: Head and neck cancer treatment evolution leads the way for future developments

April 11, 2022

As NCI-MATCH winds down, cancer research community takes stock of lessons learned

April 9, 2022

Study finds potential association between allostatic load and worse overall survival in multiple myeloma

April 9, 2022

Mixed quality of life findings following treatment highlight need for breast cancer support services

April 7, 2022

African ancestry, high BMI predictive of worse breast cancer outcomes

March 25, 2022

Enrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20%

March 17, 2022

NCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers

March 15, 2022

The results of the EA8141 phase II trial are part of mounting evidence showing the benefits of neoadjuvant chemotherapy

ECOG-ACRIN Cancer Research Group